Hovione FarmaCiencia SA
Hovione FarmaCiencia SA (Portugal) holds 14 active US FDA Type II Drug Master Files and 14 inactive, has DMF or CEP filings on record for 22 active ingredients and is linked to 4 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Hovione FarmaCiencia SA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hovione-farmaciencia-sa
Overview
Hovione FarmaCiencia SA is a privately held global pharmaceutical company headquartered in Portugal, specializing in drug substance, drug product intermediates, and particle engineering. Known for providing solutions to complex problems in pharmaceutical development and manufacturing, Hovione serves both major pharmaceutical companies and emerging biotech firms.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Hovione FarmaCiencia SA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Hovione FarmaCiencia SA holds 14 active (28 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- SALMETEROL XINAFOATE INHALATION GRADEActive2017-06-22
- FLUTICASONE FUROATE INHALATION GRADEActive2017-05-31
- MINOCYCLINE HYDROCHLORIDE MICRONIZEDActive2015-01-08
- MOMETASONE FUROATE MONOHYDRATE INHALATION GRADEActive2012-04-23
- FLUTICASONE PROPIONATE INHALATION GRADEActive2011-03-25
- DOXYCYCLINE MONOHYDRATE MICRONIZEDActive2010-03-18
- 05ST03PActive2008-07-08
- HALOBETASOL PROPIONATEActive2003-11-13
- FLUTICASONE PROPIONATEActive2002-12-20
- MOMETASONE 17-FUROATEActive2000-05-26
- MINOCYCLINE HYDROCHLORIDEActive1998-09-01
- DOXYCYCLINE MONOHYDRATEActive1998-09-01
- BETAMETHASONE 21-ACETATEActive1986-11-28
- BETAMETHASONE SODIUM PHOSPHATEActive1986-11-18
- ACLIDINIUM BROMIDE MICRONIZEDInactive2019-12-20
- MINOCYCLINEInactive2019-11-14
- BECLOMETHASONE DIPROPIONATE MONOHYDRATE USPInactive2013-05-30
- SUMATRIPTAN USPInactive2011-02-15
- IOHEXOLInactive2009-10-02
- TAMSULOSIN HYDROCHLORIDEInactive2008-07-17
- FLUMETHASONEInactive2006-11-17
- 17ST75030Inactive2004-04-23
- T-3811A15 (17TY01)Inactive2003-01-21
- DOXYCYCLINE HYCLATEInactive1998-09-01
- METHACYCLINE HYDROCHLORIDEInactive1998-09-01
- CLOBETASOL 17-PROPIONATEInactive1992-07-14
- BETAMETHASONE 17,21-DIPROPIONATEInactive1984-03-01
- BETAMETHASONE 17-VALERATEInactive1981-12-22
Registered manufacturing sites (4)
Physical sites registered with the US FDA and resolved to Hovione FarmaCiencia SA, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Hovione FarmaCiencia SA in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Hovione FarmaCiencia SA?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.